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Although serious infections due to Rhodotorula spp in humans
are rare, septicemia, endocarditis, meningitis, ventriculitis,
peritonitis, keratitis, endophthalmitis, dacryocystitis, and
pneumonia have been reported.1—4 Immunocompromised
individuals with central venous catheters are at greatest
risk.5 Few reports describe Rhodotorula spp infections in
immunocompetent individuals. We report herein two cases
of Rhodotorula glutinis fungemia in otherwise healthy men.
In both cases the isolates were identified by the API 20C AUX
system (bioMerieux, Marcy l’Etoile, France) and the identi-
fication was confirmed by the YST card in Vitek 2 system
(bioMerieux, Marcy l’Etoile, France).
Case 1. A 64-year-old man was admitted because of
altered consciousness and disorientation. Blood cultures
taken on admission yielded methicillin-resistant Staphylo-
coccus aureus; treatment with vancomycin was started. On
day 12 of hospitalization a new set of blood cultures
yielded Acinetobacter baumannii which was treated with
imipenem for 10 days. On day 25 of hospitalization he
developed a new fever and two sets of blood cultures
yielded Rhodotorula glutinis sensitive to fluconazole
(MIC 1.5 mg/mL) and resistant to 5-fluorocytosine (MIC
>32 mg/mL) by E-test (AB Biodisk, Solna, Sweden). The
patient was commenced on fluconazole 400 mg per day
intravenously. The blood cultures became negative after
48 hours. He successfully completed one month of oral
fluconazole.
Case 2. A 65-year-old manwas admittedwith community-
acquired pneumonia. He was initially treated with clarithro-
mycin and cefuroxime. On day 10 of hospitalization, the
antibiotics were empirically switched to intravenous piper-
acillin/tazobactam and ciprofloxacin due to a new fever.
Five days later due to persistent fever with negative blood
cultures, the antibiotics were again changed to a combina-
tion of imipenemand ciprofloxacin. Newblood cultures grew
R. glutinis sensitive to fluconazole (MIC 1.5 mg/mL) and
resistant to 5-fluorocytosine (MIC >32 mg/mL). Intravenous
fluconazole 400 mg daily was given and all antimicrobials
were discontinued. The patient became afebrile within
24 hours. He successfully completed four weeks of oral
fluconazole.
The previous use of broad-spectrum antibiotics was the
only predisposing factor for fungemia in our patients. The1201-9712/$32.00 # 2006 International Society for Infectious Diseases.fungi were susceptible to fluconazole and both patients
were successfully treated with this drug. Most isolates of R.
glutinis are susceptible to amphotericin B, ketoconazole,
itraconazole, and 5-fluorocytosine, and resistant to fluco-
nazole.6—10 One previous report exists of catheter-related
sepsis due to R. glutinis in a cancer patient that was
successfully treated with fluconazole and catheter
removal.7
This report supports the possible utility of in vitro fungal
susceptibility testing by E-test, although prospective studies
will prove if susceptibility testing of Rhodotorula isolates by
E-test correlates with clinical outcome.
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Tuberculosis (TB) imposes a heavy burden on the public
health system of nations, especially in an unstable political
environment such as Afghanistan. With a refugee popula-
tion of 2.1 million, Afghanistan is the largest country of
origin for refugees under United Nations High Commissioner
for Refugees (UNHCR) care. Additionally, Afghanistan has
one of the highest TB prevalence rates in the world (333 per
100 000).1
Due to a dearth of information on the characteristics of
Afghani TB patients in the world, there is no accurate
planning for detection and prevention of active disease
and latent infection among this patient group. Accordingly,
we sought to investigate the characteristics of Afghani
refugees with TB and compare them with those of native
Iranian TB patients.
This study was conducted in a tertiary TB center in Iran. All
Iranian (i.e., patient and parents were born in Iran) and
Afghani (i.e., patient and parents were born in Afghanistan)
patients with culture-confirmed TB who were hospitalized in
Masih Daneshvari Hospital from June 2003 through Septem-
ber 2004 were included in the study. Epidemiologic, clinical,
and laboratory data were collected by trained healthcare
staff using a standardized questionnaire. The total number of
TB patients in the study was 640, including 476 (74%) Iranian
patients and 164 (26%) Afghani patients. The male:female
ratio was 356:284.
There were significant differences between Iranian and
Afghani TB patients in terms of patient age, income, time
interval from the first appearance of clinical manifestations
to the first visit to the physician (patient delay), time
interval from the patient’s first visit to the physician to
the final diagnosis (system delay), weight, number of per-
sons per room at home, history of illicit drug use, and
alcohol consumption (Table 1). There were also significant
differences between the two groups of TB patients with
regard to the presence of cough and fever (91.4% and 85.4%
( p = 0.029) and 71.1% and 81.7% ( p = 0.008) in Iranian and
Afghani patients, respectively). Finally, significant differ-
ences were noted between Iranian and Afghani TB patients
in terms of sputum smear positivity, presence of BCG scar,
and multiply drug-resistant TB (MDR-TB), but there were no
differences in frequency of cavitary lesions seen on chest
X-ray.Our analysis indicates that Afghani patients were younger
than Iranian patients ( p < 0.0001), and this may indicate
the high rate of TB incidence and transmission and/or poor
TB control measures during previous years in Afghanistan.
This finding is consistent with an earlier study among immi-
grants in Canada.2 In this study, as in ours, there was no
significant difference between the two groupswith regard to
gender. However, others have reported a gender difference
that may be explained by underdiagnosis or underreporting
of TB or differences in transmission dynamics in female
patients.3,4
Afghani patients had lower socioeconomic status and
higher number of persons per household compared to
Iranian TB patients, which probably demonstrates the
relationship between TB and poverty.5 Both patient
and system delays were significantly longer in Afghani
patients, which may relate to differences in patient knowl-
edge of TB and access to medical facilities in these two
populations.
The prevalence of cough was significantly higher among
Iranian patients, whereas fever and night sweats were
more frequently seen in Afghani subjects. It has been
shown that the prevalence of fever and night sweats is
higher in young adults compared to elderly populations,6
and this may be explained by our younger Afghani popula-
tion.
A BCG scar was detected more often in Iranian patients.
The rate of smear positivity (>+3) was significantly higher in
Afghani patients, which could be due to more advanced
disease, perhaps related to longer patient and system delays.
A higher proportion of Afghani patients also had more fre-
quent MDR-TB. This might be explained by the presence of
more resistant strains of Mycobacterium tuberculosis, such
as theW-strain, among Afghani patients, or the result of more
frequent treatment interruptions in non-adherent refugee
patients. A study in the USA showed that immigrant patients
weremore likely to be resistant to at least one drug than non-
immigrant Americans.7
In summary, most of the contrasting epidemiologic fea-
tures of Afghani and Iranian patients with TB seem to relate
to the lower socioeconomic status of Afghanis, both inside
their home country and while living in Iran, and/or to the
higher TB prevalence inside Afghanistan (includingMDR-TB).
The distinct epidemiologic features of the Iranian TB
patients (including the higher incidence of HIV/AIDS) can
be explained by lifestyle differences within a more affluent
population. Our results should encourage health policy-
makers to strengthen efforts to detect and treat both latent
